Effect of a Novel Trivalent Vaccine Formulation against Acute Lung Injury Caused by <i>Pseudomonas aeruginosa</i>

An effective vaccine against <i>Pseudomonas aeruginosa</i> would benefit people susceptible to severe infection. Vaccination targeting V antigen (PcrV) of the <i>P. aeruginosa</i> type III secretion system is a potential prophylactic strategy for reducing <i>P. aerugino...

Full description

Bibliographic Details
Published in:Vaccines
Main Authors: Keita Inoue, Mao Kinoshita, Kentaro Muranishi, Junya Ohara, Kazuki Sudo, Ken Kawaguchi, Masaru Shimizu, Yoshifumi Naito, Kiyoshi Moriyama, Teiji Sawa
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Subjects:
bacterial components
infection immunity
toxin
pathogenesis
trivalent vaccine
Online Access:https://www.mdpi.com/2076-393X/11/6/1088

Internet

https://www.mdpi.com/2076-393X/11/6/1088

Similar Items